- Home
- NOVT vs RLAY Comparison
NOVT vs RLAY Comparison
Compare NOVT & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NOVT | RLAY |
|---|---|---|
| Founded | 1968 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.1B |
| IPO Year | 1999 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NOVT | RLAY |
|---|---|---|
| Price | $148.36 | $19.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $144.00 | $19.50 |
| AVG Volume (30 Days) | 282.0K | ★ 2.2M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $521,290,000.00 | $15,355,000.00 |
| Revenue This Year | $8.61 | N/A |
| Revenue Next Year | $6.57 | $324.03 |
| P/E Ratio | $180.93 | ★ N/A |
| Revenue Growth | 35.49 | ★ 53.44 |
| 52 Week Low | $98.27 | $3.89 |
| 52 Week High | $176.38 | $21.27 |
Technical Indicators
Market Signals| Indicator | NOVT | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 47.04 | 43.70 |
| Support Level | $146.45 | $18.02 |
| Resistance Level | $149.42 | $20.82 |
| Average True Range (ATR) | 6.14 | 0.87 |
| MACD | -0.65 | -0.24 |
| Stochastic Oscillator | 27.39 | 21.00 |
Price Performance
Historical ComparisonAbout NOVT Novanta Inc.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.